| 1 | ALNY | Alnylam Pharmaceuticals, Inc. | 5.26% |
| 2 | CRSP | CRISPR Therapeutics AG | 4.89% |
| 3 | ILMN | Illumina, Inc. | 4.84% |
| 4 | QGEN | Qiagen N.V. | 4.43% |
| 5 | NTRA | Natera, Inc. | 4.37% |
| 6 | GH | Guardant Health, Inc. | 4.32% |
| 7 | TECH | Bio-Techne Corporation | 4.09% |
| 8 | MRNA | Moderna, Inc. | 4.00% |
| 9 | RARE | Ultragenyx Pharmaceutical Inc. | 3.97% |
| 10 | LEGN | Legend Biotech Corporation | 3.85% |
| 11 | RNA | Avidity Biosciences, Inc. | 3.85% |
| 12 | BNTX | BioNTech SE | 3.61% |
| 13 | VRTX | Vertex Pharmaceuticals Incorporated | 3.58% |
| 14 | BMRN | BioMarin Pharmaceutical Inc. | 3.46% |
| 15 | WGS | GeneDx Holdings Corp. | 2.86% |
| 16 | HKG: 1548 | Genscript Biotech Corporation | 2.74% |
| 17 | TWST | Twist Bioscience Corporation | 2.70% |
| 18 | VCYT | Veracyte, Inc. | 2.63% |
| 19 | ARWR | Arrowhead Pharmaceuticals, Inc. | 2.31% |
| 20 | A | Agilent Technologies, Inc. | 2.23% |
| 21 | LON: AZN | AstraZeneca PLC | 2.00% |
| 22 | GILD | Gilead Sciences, Inc. | 1.96% |
| 23 | BMY | Bristol-Myers Squibb Company | 1.90% |
| 24 | LLY | Eli Lilly and Company | 1.88% |
| 25 | BEAM | Beam Therapeutics Inc. | 1.86% |
| View GNOM holdings |
